公开(公告)号：US20250134884A1

公开(公告)日：2025-05-01

申请号：US18926048

申请日：2024-10-24

Applicant: LUMISTAR BIOTECHNOLOGY, INC. ,  ACADEMIA SINICA

Inventor： Chia-Ning SHEN ,  Edward Po-Fan CHU ,  Jen-Chieh CHENG ,  Yu-Fen CHANG ,  Wan-Chi SU ,  Min-Wen CHUNG

IPC: A61K31/496 ,  A61P3/10

Abstract: A method for treating Type II diabetes. The method involves administering to a subject a pharmaceutical composition comprising an effective amount of a 5-HT1A receptor antagonist. The pharmaceutical composition comprises an effective amount of a 5-HT1A receptor antagonist, and pharmaceutically acceptable carriers thereof.